Risk Factors for Clinician-Reported Symptom Clusters in Patients with Advanced Head and Neck Cancer in a Phase III Randomized Clinical Trial: RTOG 0129

Antzeko izenburuak

• Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy
  nork: Xiao, Canhua, et al.
  Argitaratua: (2012)
• Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129
  nork: Xiao, Canhua, et al.
  Argitaratua: (2016)
• The Impact of Gender, Partner Status, and Race on Locoregional Failure and Overall Survival in Head and Neck Cancer Patients in Three Radiation Therapy Oncology Group (RTOG) Trials
  nork: Dilling, Thomas J., et al.
  Argitaratua: (2011)
• Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
  nork: Nguyen-Tan, Phuc Felix, et al.
  Argitaratua: (2014)
• Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
  nork: Ang, K. Kian, et al.
  Argitaratua: (2014)